In the dynamic field of bioprocessing, the ability to continuously monitor and control critical parameters like glucose and lactate levels in cell cultures is pivotal. These parameters directly impact the optimization of bioreactor conditions, ensuring efficient research and development of biopharmaceutical products. By integrating Getinge’s bioreactors with 908 Devices’ MAVEN system, a groundbreaking solution has emerged, providing automated, real-time control of glucose and lactate levels. This collaboration promises to transform workflows, enhance productivity, and accelerate time-to-market for biopharma innovations.
Accurate monitoring of glucose and lactate concentrations is essential for maintaining optimal bioreactor conditions. Traditionally, these measurements required manual sampling, which could be time-consuming and introduce variability. The MAVEN system from 908 Devices eliminates these challenges by offering precise, on-line monitoring without reducing bioreactor volume. Its ability to measure critical nutrient and metabolite levels, even at extremely low concentrations, ensures that scientists can sustain the ideal environment for cell culture growth.
The MAVEN seamlessly integrates with Getinge’s advanced controllers, allowing for sophisticated data analysis and control strategies. Equipped with features like control loops, recipe functionality, and advanced control, Getinge’s systems can supervise up to two bioreactors simultaneously, streamlining operations for biopharma labs.
Enhanced Automation for Seamless Lab Workflows
This collaboration was born out of a shared vision to provide modern automation tools that empower biopharma researchers. Timo Keijzer, Director of Product Marketing at Getinge, expressed his enthusiasm for the partnership:
“We are thrilled to collaborate with 908 Devices on this joint solution to make our customers’ life in the lab easier. This means continuous visibility into concentration changes, control over glucose levels, and the ability to adjust strategies based on real-time measurements. For instance, users can start feeding processes or halt cultivation promptly. These capabilities enable increased productivity and faster time-to-market.”
Christopher D. Brown, Chief Product Officer and Co-founder at 908 Devices, echoed these sentiments, emphasizing the significance of the partnership in advancing biopharma research:
“We’re excited to partner with Getinge as we share a mutual passion for enabling our biopharma customers with modern bioprocess automation tools. By enhancing control of critical process parameters, we are increasing process understanding and accelerating development workflows. Robust control strategies implemented during development optimize product performance and establish scalable processes for the future.”
Advanced Connectivity and Compatibility
A key feature of this collaboration is the MAVEN device’s compatibility with Getinge’s Livit Flex controller, connecting effortlessly through Livit Links sensor ports. This integration facilitates continuous monitoring and control, providing users with a comprehensive, automated solution tailored to the complexities of biopharmaceutical production.
By combining MAVEN’s precise analytical capabilities with Getinge’s state-of-the-art control systems, this partnership offers a powerful tool for scientists aiming to enhance productivity, improve product quality, and streamline workflows.
About Getinge
Getinge is driven by a commitment to ensuring that every individual and community has access to exceptional care. The company provides hospitals and life science institutions with products and solutions designed to improve clinical outcomes and optimize workflows. Getinge’s portfolio includes offerings for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life sciences. Employing approximately 12,000 people worldwide, Getinge serves customers in over 135 countries, making it a global leader in life sciences and healthcare innovation.
About 908 Devices
908 Devices is at the forefront of chemical analysis, developing portable and desktop devices that revolutionize applications in bioprocessing, pharma, forensics, and life sciences. By combining advanced analytical technologies, microfluidic sampling, software automation, and machine learning, 908 Devices delivers solutions that provide rapid, actionable insights. Headquartered in Boston, the company continues to innovate, addressing critical challenges across multiple industries with its cutting-edge technologies.
This partnership between Getinge and 908 Devices represents a significant advancement in bioprocess automation, heralding a new era of efficiency and precision in the biopharmaceutical industry.
Source Link
